About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Bone Marrow Transplantation
›
Top Articles
Bone Marrow Transplantation
Transplantation
,
Hematology
4.4
(top 3%)
Impact Factor
4.8
(top 3%)
extended IF
135
(top 2%)
H-Index
4K
authors
12K
papers
273.1K
citations
5.7K
citing journals
47.9K
citing authors
Most Cited Articles of Bone Marrow Transplantation
Title
Year
Citations
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
2013
7.5K
1994 Consensus Conference on Acute GVHD Grading
1995
3.4K
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
2002
514
Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use
1995
481
Competing risk analysis using R: an easy guide for clinicians
2007
462
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update
2011
359
Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation
2004
358
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury
2007
355
Regression modeling of competing risk using R: an in depth guide for clinicians
2010
312
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
2006
308
Engraftment syndrome following hematopoietic stem cell transplantation
2001
286
Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale
1997
283
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
2016
265
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation
2003
261
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
2009
259
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface
2009
259
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics
1995
243
Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children
2001
242
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
2009
240
Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines
2003
240
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants
1992
240
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
2017
235
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
2015
226
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
2010
225
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium
1998
225
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.